Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Pacific Biosciences of California Inc PACB

Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing... see more

Recent & Breaking News (NDAQ:PACB)

Highly Accurate Long-Read Sequencing of Human Genomes Leads to Discovery of Disease-Causing Variants

GlobeNewswire June 13, 2019

Highly Accurate Long-Read Sequencing of Human Genomes Leads to Discovery of Disease-Causing Variants

Thomson Reuters ONE June 13, 2019

Pacific Biosciences of California, Inc. Announces First Quarter 2019 Financial Results

GlobeNewswire May 3, 2019

Pacific Biosciences Launches New Sequel II System, Featuring ~8 Times the DNA Sequencing Data Output

GlobeNewswire April 24, 2019

Transplant Matches Identified by Ultra-High-Resolution HLA Typing Associated with Higher Patient Survival Rates

GlobeNewswire April 2, 2019

The Daily Biotech Pulse: NASH Disappointment For Gilead, Xeris To Offer Shares

Benzinga.com  February 12, 2019

Pacific Biosciences Announces Fourth Quarter and Annual 2018 Financial Results

GlobeNewswire February 11, 2019

Report: Exploring Fundamental Drivers Behind SkyWest, Pacific Biosciences of California, Lennar, Regeneron Pharmaceuticals, MGM Growth Properties, and Cincinnati Bell — New Horizons, Emerging Trends, and Upcoming Developments

GlobeNewswire January 17, 2019

Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Red Hat, LSC Communications, Intersections, and Pacific Biosciences on Behalf of Stockholders and Encourages Investors to Contact the Firm

GlobeNewswire December 31, 2018

Wolf Haldenstein Adler Freeman & Herz LLP announces that it has filed a class action complaint in the United States District Court for the Northern District of California on behalf of holders of Pacific Biosciences of California, Inc.

GlobeNewswire December 12, 2018

Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Pacific Biosciences of California, Inc. (PACB) on Behalf of Stockholders and Encourages PACB Investors to Contact the Firm

GlobeNewswire December 10, 2018

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

Business Wire December 7, 2018

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Pacific Biosciences of California, Inc. - PACB

PR Newswire December 6, 2018

PacBio’s SMRT Sequencing Provides Unprecedented Insight into Genome of Disease-causing Mosquito

GlobeNewswire November 14, 2018

Consolidated Research: 2018 Summary Expectations for Pacific Biosciences of California, NXP Semiconductors N.V., Consolidated Communications, Alexander & Baldwin, Willdan Group, and OneMain — Fundamental Analysis, Key Performance Indications

GlobeNewswire November 7, 2018

Thinking about buying stock in Apple, Aurora Cannabis Inc, Canadian Solar, Lowes or Pacific Biosciences?

PR Newswire November 5, 2018

Mid-Afternoon Market Update: Dow Falls 270 Points; Weight Watchers Shares Tumble After Q3 Results

Benzinga.com  November 2, 2018

Mid-Day Market Update: Dow Down 100 Points; Pacific Biosciences of California Shares Spike Higher

Benzinga.com  November 2, 2018

Mid-Morning Market Update: Markets Mostly Higher; Apple Issues Weak Sales Forecast

Benzinga.com  November 2, 2018

Illumina Buys Rival Pacific Biosciences In $1.2B Deal

Benzinga.com  November 2, 2018